Skip to main content
Posted on 10 Feb 2021
Share news

Authorization to manufacture investigational medicinal products

VIVEbiotech obtains authorization to manufacture investigational medicinal products.

Authorization to manufacture investigational medicinal products

On February 9, VIVEbiotech obtained the authorization from the Spanish Agency of Medicines and Medical Devices (AEMPS) to manufacture investigational medicinal products.

The new document reflects the following scope and dosage forms:

  • Manufacturer of sterile or biological active substances
  • Manufacturer of investigational medicinal products

The new authorization of “Manufacturer of investigational medicinal products” authorizes VIVEbiotech to manufacture drugs that will be administered in vivo in clinical trials.

You can check the new authorization issued by the AEMPS here.